Our capabilities and experience
Read more about how we help manage complex clinical research across many therapeutic areas worldwide.
Page 3 of 6
Action Items From the PREVAIL Network Site Visit
Watch this video to learn about the action items put into place following a visit to each of the PREVAIL network sites in Liberia, such as implementing productivity metrics and clarifying roles and responsibilities.
Training, Knowledge and Skills for the PREVAIL Network Site Staff
Following a trip to the PREVAIL network of sites in Liberia, we asked FHI Clinical team members for their feedback on the types of training, knowledge and skills that are important for the site staff to encompass. Watch this video to learn what qualities the experts evaluated during their trip.
Takeaways From the PREVAIL Network Trip
Upon their return from visiting Liberia and the PREVAIL network sites, we asked a team of FHI Clinical experts what they learned during their time in the country.
Purpose of the Visit to the PREVAIL Network in Liberia
In the fall of 2021, a small team from FHI Clinical headed to Liberia to meet the FHI Clinical PREVAIL network team. Watch this video to learn more about the purpose and goals of their trip.
We Are Mission Driven
Our team is caring, passionate and working towards the same goal: to address unmet research needs and achieve maximum social impact by supporting the development of life-saving vaccines and medicines. Watch the video to learn why our team thinks being mission-driven makes FHI Clinical a special place to work.
We Partner With Our Sites
Our site managers partner with study sites to ensure their success throughout the length of the project. This can include training and re-training for procedures, processes, protocol, ICH GCP, data management, informed consent and more.
How We Build Research Capacity
We believe that building and sustaining research capacity, particularly in resource-limited, research-naïve areas, will help address public health issues around the globe. Watch the video to learn how our teams support sites to develop sustainable research capacity and produce high-quality study data. In addition, we work with regional institutions to establish networks of research-ready sites that focus on local health and research priorities.
Coronaviruses Fact Sheet
Discovered in the 1960s, coronaviruses (CoV) are a large group of RNA viruses in the family Coronaviridae that cause disease in humans and animal species. Human illness includes respiratory infections that range from the common cold to viral (direct) or bacterial (indirect) pneumonia and are especially serious in infants and at-risk adults. There are seven known coronavirus types/strains.
About the PREVAIL Network
The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network was established through a partnership between local Liberian and international partners, including the U.S. National Institutes of Health, World Health Organization and FHI Clinical, to provide sustainable research infrastructure to address diseases of public health importance.
Celebrating Our 2-Year Anniversary
We’re proud of our progress and remain committed to and passionate about our mission-driven work globally.
